2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine

C114H115Cl5N22O8S — CID 158112551

IUPAC2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine
SMILESC=C(C)c1cn2c(CN3CCOCC3)c(-c3ccc(Cl)cc3)nc2cn1.CC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4C#N)cn23)CC1.CC(C)c1cn2c(CN3CCOCC3)c(-c3ccc(Cl)cc3)nc2cn1.COCC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4C#N)cn23)CC1.CS(=O)(=O)Nc1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCOCC3)n2c1
InChIInChI=1S/C28H26ClN5O2.C27H24ClN5O.C20H23ClN4O.C20H21ClN4O.C19H21ClN4O3S/c1-36-19-27(35)33-14-12-32(13-15-33)18-25-28(20-6-9-23(29)10-7-20)31-26-11-8-22(17-34(25)26)24-5-3-2-4-21(24)16-30;1-19(34)32-14-12-31(13-15-32)18-25-27(20-6-9-23(28)10-7-20)30-26-11-8-22(17-33(25)26)24-5-3-2-4-21(24)16-29;2*1-14(2)17-12-25-18(13-24-7-9-26-10-8-24)20(23-19(25)11-22-17)15-3-5-16(21)6-4-15;1-28(25,26)22-16-6-7-18-21-19(14-2-4-15(20)5-3-14)17(24(18)12-16)13-23-8-10-27-11-9-23/h2-11,17H,12-15,18-19H2,1H3;2-11,17H,12-15,18H2,1H3;3-6,11-12,14H,7-10,13H2,1-2H3;3-6,11-12H,1,7-10,13H2,2H3;2-7,12,22H,8-11,13H2,1H3
InChIKeyFQPOQEIBFXOQRX-UHFFFAOYSA-N
MW2130.65 g/mol
LogP20.12
Rot. Bonds23

About 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine

2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine (PubChem CID 158112551) has the molecular formula C114H115Cl5N22O8S and a molecular weight of 2130.65 g/mol. Its IUPAC name is 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine.

Molecular Properties

Compound Name2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine
PubChem CID158112551
Molecular FormulaC114H115Cl5N22O8S
Molecular Weight2130.65 g/mol
Exact Mass2126.74
IUPAC Name2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine
SMILESC=C(C)c1cn2c(CN3CCOCC3)c(-c3ccc(Cl)cc3)nc2cn1.CC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4C#N)cn23)CC1.CC(C)c1cn2c(CN3CCOCC3)c(-c3ccc(Cl)cc3)nc2cn1.COCC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4C#N)cn23)CC1.CS(=O)(=O)Nc1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCOCC3)n2c1
InChIInChI=1S/C28H26ClN5O2.C27H24ClN5O.C20H23ClN4O.C20H21ClN4O.C19H21ClN4O3S/c1-36-19-27(35)33-14-12-32(13-15-33)18-25-28(20-6-9-23(29)10-7-20)31-26-11-8-22(17-34(25)26)24-5-3-2-4-21(24)16-30;1-19(34)32-14-12-31(13-15-32)18-25-27(20-6-9-23(28)10-7-20)30-26-11-8-22(17-33(25)26)24-5-3-2-4-21(24)16-29;2*1-14(2)17-12-25-18(13-24-7-9-26-10-8-24)20(23-19(25)11-22-17)15-3-5-16(21)6-4-15;1-28(25,26)22-16-6-7-18-21-19(14-2-4-15(20)5-3-14)17(24(18)12-16)13-23-8-10-27-11-9-23/h2-11,17H,12-15,18-19H2,1H3;2-11,17H,12-15,18H2,1H3;3-6,11-12,14H,7-10,13H2,1-2H3;3-6,11-12H,1,7-10,13H2,2H3;2-7,12,22H,8-11,13H2,1H3
InChIKeyFQPOQEIBFXOQRX-UHFFFAOYSA-N
XLogP20.12
TPSA299.77 Ų
H-Bond Donors1
H-Bond Acceptors27
Rotatable Bonds23
Heavy Atoms150
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002130.65
LogP ≤ 520.12
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1027

Analyze 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine?
The IUPAC name of 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine (CID 158112551) is 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine.
What is the SMILES notation for 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine?
The canonical SMILES for 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine is C=C(C)c1cn2c(CN3CCOCC3)c(-c3ccc(Cl)cc3)nc2cn1.CC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4C#N)cn23)CC1.CC(C)c1cn2c(CN3CCOCC3)c(-c3ccc(Cl)cc3)nc2cn1.COCC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4C#N)cn23)CC1.CS(=O)(=O)Nc1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCOCC3)n2c1.
What is the InChIKey of 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine?
The InChIKey is FQPOQEIBFXOQRX-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H26ClN5O2.C27H24ClN5O.C20H23ClN4O.C20H21ClN4O.C19H21ClN4O3S/c1-36-19-27(35)33-14-12-32(13-15-33)18-25-28(20-6-9-23(29)10-7-20)31-26-11-8-22(17-34(25)26)24-5-3-2-4-21(24)16-30;1-19(34)32-14-12-31(13-15-32)18-25-27(20-6-9-23(28)10-7-20)30-26-11-8-22(17-33(25)26)24-5-3-2-4-21(24)16-29;2*1-14(2)17-12-25-18(13-24-7-9-26-10-8-24)20(23-19(25)11-22-17)15-3-5-16(21)6-4-15;1-28(25,26)22-16-6-7-18-21-19(14-2-4-15(20)5-3-14)17(24(18)12-16)13-23-8-10-27-11-9-23/h2-11,17H,12-15,18-19H2,1H3;2-11,17H,12-15,18H2,1H3;3-6,11-12,14H,7-10,13H2,1-2H3;3-6,11-12H,1,7-10,13H2,2H3;2-7,12,22H,8-11,13H2,1H3.
What are the key properties of 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine?
2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine has a molecular weight of 2130.65 g/mol, XLogP of 20.12, 23 rotatable bonds, 1 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine is sourced from PubChem (CID 158112551), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).